Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Blast Crisis × Dexamethasone × Clear all

Phase

Status

Sponsor Class

OTHER 7 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 299 Recurrence 63 Neoplasms 32 Neoplasms, Plasma Cell 17 Lymphoma, Non-Hodgkin 14 Carcinoma, Non-Small-Cell Lung 13 Prostatic Neoplasms 12 Vomiting 11 Neoplasm Metastasis 8 Leukemia, Myeloid, Acute 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Nausea 7 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma 7 Ovarian Neoplasms 6 Immunoglobulin Light-chain Amyloidosis 6 Hematologic Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Paraproteinemias 5 Lung Neoplasms 5 Leukemia 5 Small Cell Lung Carcinoma 4 Renal Insufficiency 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Plasmacytoma 4 Lymphoma, Follicular 4 Hematologic Diseases 4 Leukemia, Plasma Cell 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Breast Neoplasms 3

Interventions

nilotinib 4 Imatinib Mesylate 4 Dasatinib 4 troxacitabine 1 ponatinib 1 litronesib 1 exatecan 1 carfilzomib 1 bosutinib 1 blinatumomab 1 asciminib 1 TAK-901 1 STA 9090 1 Panobinostat 1 Homoharringtonine 1 Fentanyl 1 Dexamethasone 1 Decitabine 1 Calcium Dobesilate 1 2-(2-oxo-2-((3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy)aminoethyl)phosphonic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester sodium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01204164 2016-05-06

TG02-101

Tragara Pharmaceuticals, Inc.

Phase 1 Completed

Blast Crisis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡